REVB
Price
$0.99
Change
-$0.00 (-0.00%)
Updated
Sep 11 closing price
Capitalization
3.98M
54 days until earnings call
Intraday BUY SELL Signals
SABS
Price
$3.41
Change
-$0.01 (-0.29%)
Updated
Sep 11 closing price
Capitalization
309.35M
66 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

REVB vs SABS

REVB vs SABS Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
REVB vs. SABS commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is REVB is a Hold and SABS is a Buy.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SABS($309M) has a higher market cap than REVB($3.98M). SABS has higher P/E ratio than REVB: SABS (14.17) vs REVB (0.04). SABS YTD gains are higher at: -8.824 vs. REVB (-68.980). SABS has higher annual earnings (EBITDA): -9.43M vs. REVB (-11.24M). SABS has more cash in the bank: 103M vs. REVB (11.5M). REVB has less debt than SABS: REVB (740K) vs SABS (5.13M). REVB (0) and SABS (0) have equivalent revenues.
REVBSABSREVB / SABS
Capitalization3.98M309M1%
EBITDA-11.24M-9.43M119%
Gain YTD-68.980-8.824782%
P/E Ratio0.0414.170%
Revenue00-
Total Cash11.5M103M11%
Total Debt740K5.13M14%
TECHNICAL ANALYSIS
Technical Analysis
REVBSABS
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 10 days ago
80%
Bullish Trend 17 days ago
80%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
87%
Aroon
ODDS (%)
N/A
Bearish Trend 5 days ago
90%
COMPARISON
Comparison
Sep 13, 2026
Stock price -- (REVB: $0.99 vs. SABS: $3.41)
Brand notoriety: REVB and SABS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: REVB: 8% vs. SABS: 267%
Market capitalization -- REVB: $3.98M vs. SABS: $309.35M
REVB [@Biotechnology] is valued at $3.98M. SABS’s [@Biotechnology] market capitalization is $309.35M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $130.64B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

REVB’s FA Score shows that 2 FA rating(s) are green while SABS’s FA Score has 0 green FA rating(s).

  • REVB’s FA Score: 2 green, 3 red.
  • SABS’s FA Score: 0 green, 5 red.
According to our system of comparison, REVB is a better buy in the long-term than SABS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

REVB’s TA Score shows that 3 TA indicator(s) are bullish while SABS’s TA Score has 4 bullish TA indicator(s).

  • REVB’s TA Score: 3 bullish, 5 bearish.
  • SABS’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both REVB and SABS are a bad buy in the short-term.

Price Growth

REVB (@Biotechnology) experienced а -0.76% price change this week, while SABS (@Biotechnology) price change was -8.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.09%. For the same industry, the average monthly price growth was -3.45%, and the average quarterly price growth was +2531.70%.

Reported Earning Dates

REVB is expected to report earnings on Nov 05, 2026.

SABS is expected to report earnings on Nov 17, 2026.

Industries' Descriptions

@Biotechnology (-6.09% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
REVB
Daily Signal:
Gain/Loss:
SABS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TRSPX81.64N/A
N/A
Nuveen S&P 500 Index Retire
RLECX24.56N/A
N/A
Russell Inv US Small Cap Equity C
SAUMX36.75N/A
N/A
SA US Small Company
VELIX17.24N/A
N/A
VELA Large Cap Plus I
RDWBX16.43-0.15
-0.90%
American Funds Dvlpg Wld Gr&Inc R-2

REVB and

Correlation & Price change

A.I.dvisor indicates that over the last year, REVB has been closely correlated with INKT. These tickers have moved in lockstep 80% of the time. This A.I.-generated data suggests there is a high statistical probability that if REVB jumps, then INKT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To REVB
1D Price
Change %
REVB100%
+0.34%
INKT - REVB
80%
Closely correlated
+0.58%
GNPX - REVB
48%
Loosely correlated
N/A
SABS - REVB
48%
Loosely correlated
-0.29%
TCRT - REVB
46%
Loosely correlated
-1.32%
ANL - REVB
33%
Loosely correlated
+0.80%
More

SABS and

Correlation & Price change

A.I.dvisor indicates that over the last year, SABS has been loosely correlated with REVB. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if SABS jumps, then REVB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SABS
1D Price
Change %
SABS100%
-0.29%
REVB - SABS
48%
Loosely correlated
+0.34%
INKT - SABS
47%
Loosely correlated
+0.58%
CYPH - SABS
46%
Loosely correlated
+2.95%
TECX - SABS
35%
Loosely correlated
+1.54%
BEAM - SABS
31%
Poorly correlated
-1.56%
More